Spartan researchers have been awarded $2.2 million to investigate how the diets of expecting mothers could affect their babies’ heart health. Nearly one out of every 100 babies…
We live in a critical time when bacteria have demonstrated an ability to develop resistance to every known antibiotic, and new antibiotic development has been nearly nonexistent for…
A Michigan State University study led by a physiology graduate student in the College of Human Medicine has found that new drug combinations may prevent melanoma, an often…
Three people with ties to Michigan State University and the Department of Pharmacology and Toxicology have been named to the 2019 inaugural class of Fellows of the American Society of…
In 2013 while Richard Neubig, professor and chair of MSU’s pharmacology and toxicology department, was conducting research on cardiovascular disease using mouse models with a Gnao1 protein mutation,…
Michigan State University scientists will use the latest CRISPR technology to study two extremely rare genetic mutations that leave children severely disabled with seizures and involuntary movements. CRISPR,…
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for…
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule…
This year, four Michigan State University scientists were named AAAS Fellows by the American Association for the Advancement of Science. This national recognition is awarded to researchers for…
Richard Neubig, chair of the Department of Pharmacology and Toxicology at Michigan State University, discusses the potential for pharmacological intervention in scleroderma/systemic sclerosis cases. This presentation was given at…
Research at Michigan State University